Journal of Dermatological Treatment

Article	Citations
The hf-PGA is a valid and reliable measure of hand/foot psoriasis severity in adults: results from a phase 2b clinical trial	82
Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis	71
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Regist	67
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa	55
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab	46
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy	44
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Pso	38
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks	38
A CollaboraTive Initiative of worldwide Vitiligo Experts and patients to define vitiligo activity (ACTIVE): study protocol	34
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial	31
Topical delgocitinib for the treatment of chronic hand eczema	28
A systematic review of recent randomized controlled trials for palmoplantar pustulosis	28
Skin type classifications: does the perfect assessment exist?	26
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most	26
Lessons from a decentralized trial in atopic dermatitis: promises and perils	26
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants	25
Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits	24
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)	24
Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study	22
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry	21
Long-Term efficacy and safety analysis of secukinumab in the treatment of pediatric generalized pustular psoriasis: a real-world study	21
A pediatric case of dupilumab-induced pustular psoriasis	21
Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients	21
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study	20
Finally, successful interventions to ameliorate cutaneous infestations	20

Efficacy and safety of sofpironium in treatment of primary hyperhidrosis: a systematic review	20
The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy	20
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)	20
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years	19
The effect of tildrakizumab on adipokines production in patients affected by psoriasis and obesity: preliminary results from a single center real-life study	19
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis	19
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study	19
Driving taxis	19
The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study	19
Off-label use of upadacitinib in dermatology: a review	18
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study –	18
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses	17
Rapid improvement of kimura disease with dupilumab in a patient with suboptimal response to mepolizumab: a case report	17
Clinical observation of 10 cases of stable non-segmental vitiligo in adults treated with upadacitinib	17
Preoperative and postoperative evaluation of survivin in peripheral blood of patients with non-melanoma skin cancers. A pilot study	17
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study	17
Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis	16
A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiency	16
The changes of leukocytes and T lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in control group in pollen season compared to out of pollen season	16
Correction	16
Efficacy of skin flap transfer combined with negative pressure wound therapy in the management of complex pressure ulcers	15
Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa	15
Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib	15
Psychosocial interventions for psoriasis: a Bayesian network meta-analysis	15
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review	15
Systematic review, methodological appraisal, and recommendation mapping of clinical practice guidelines for managing patients with Stevens-Johnson syndrome and toxic epidermal necrolysis	15
Exploring the potential of nanocarriers in antipsoriatic therapeutics	15
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers	15
Racial disparities in the management of skin ulcers: an analysis of the National Ambulatory Medical Care Survey, 2012–2018	15
Predictive factors for early super response to bimekizumab in 341 patients with psoriasis—a 24-week short-term multicenter real-life experience	15
Correction	14
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD	14
A practical algorithm for the treatment of mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe: expert recommendations	14
From clinical trial to real world evidence: a learning healthcare environment	14
Pre-operative ultrasound localization of misdiagnosed foreign object as verruca vulgaris: a case report	14
Depression and depressive symptoms among people living with vitiligo: findings from the cross-sectional, population-based global VALIANT survey	13
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis	13
Uses of eye drops in dermatology, literature review	13
Years of dermatology experience and geographic region are associated with outlier performance of excision or destruction for nonmelanoma skin cancer	13
Photodynamic therapy combined with surgery versus Mohs micrographic surgery for the treatment of difficult-to-treat basal cell carcinoma: a retrospective clinical study	13
Utilizing artificial intelligence technology with emotional intelligence in clinical office visits	13
Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study	13
Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network	13
Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report	13
A new method to treat onychopapilloma with pulsed dye laser irradiation: a 13-case series report	12
Polynucleotide-based treatments for various facial scars including combat injuries	12
Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin	12
Successful treatment of SAPHO syndrome with oral abrocitinib: a case report	12
Vitiligo outpatient management in the United States: findings from the 2012–2019 National Ambulatory Medical care Survey (NAMCS)	12
Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab	12

Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders	12
Dupilumab in papuloerythroderma of Ofuji: therapeutic efficacy and paradoxical flares in a case-based review	12
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study	12
Boxed warnings for dermatologic JAK inhibitors: are they standardized worldwide?	12
The development and initial evaluation of conversation cards for optimizing consultations for patients with atopic dermatitis	12
Comparative efficacy of targeted systemic therapies for pruritus in moderate-to-severe atopic dermatitis without topical treatment: a network meta-analysis	12
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study	12
Managing dry skin in patients with comorbidities or with advanced age: unmet needs and roles for products containing potential emollient-plus ingredients	12
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis	11
Teledermatological services at a Swiss university hospital - evaluation of patient benefits and economic impact	11
Social determinants of health, quality of life, and productivity outcomes among adults with vitiligo in Brazil, China, India, and South Africa	11
Phototherapy trends in dermatology 2015–2018	11
Non-medical switching in dermatology: cost-conscious policy or an affront to patient safety?	11
Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan	11
Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience	10
Invasive Aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate, and corticosteroids for psoriasis and psoriatic arthritis	10
Improving the quality of life of patients with inflammatory skin diseases: a multicenter evaluation of a ceramide-containing regimen in patients with atopic dermatitis, psoriasis and xerosis	10
Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis	10
Characterization and therapeutic strategies for refractory vulvar lichen sclerosus: an 8-year single-center retrospective study and current evidence synthesis	10
Initiation of apremilast treatment decreases prescribed topical therapy amount in patients with psoriasis: a health insurance claims study in Japan	10
Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special	9
Botanical extract combined with minoxidil improve hidrotic ectodermal dysplasia caused by p.G11R mutations: a case report	9
New insights into delusional infestation	9
Successful treatment of generalized pustular psoriasis during pregnancy with secukinumab in a patient hypersensitive to spesolimab: a case report	9
Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin	9
The efficacy of combined phototherapy with topical therapy in vitiligo: a network meta-analysis	9
Biodegradable polymers and platelet-rich plasma causing visual impairment: a literature review	9
Multiple COVID reinfections in a vaccinated psoriatic patient receiving adalimumab	9
Treatment of eosinophilic annular erythema with upadacitinib	9
Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis	9
Another transition	9
Efficacy of oral isotretinoin monotherapy compared to combination isotretinoin and topical clascoterone for severe acne vulgaris: a multi-center retrospective study	9
Doxycycline monotherapy for pyoderma vegetans: a case report	9
Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry	9
Apremilast in the treatment of pityriasis lichenoides et varioliformis acuta: a case report	9
Complementary and alternative treatment methods practiced by parents in pediatric cases diagnosed with atopic dermatitis	9
Evaluation of innate lymphoid cells and their subsets in atopic dermatitis patients with and without dupilumab therapy	9
Real-world use, perception, satisfaction, and adherence of calcipotriol and betamethasone dipropionate PAD-cream in patients with plaque psoriasis in Spain and Germany: results from a cross-sectional,	8
Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo	8
A case of generalized eosinophilic pustular folliculitis: treatment with JAK inhibitor	8
Experiences and coping behaviors of patients with psoriasis: a qualitative study	8
Efficacy and safety of stromal vascular fraction on scar revision surgery: a prospective study	8
Delusional infestation: a case for preserving pimozide as an option	8
Personalized prediction of psoriasis relapse post-biologic discontinuation: a machine learning-driven population cohort study	8
Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial	8
Comparing Mohs micrographic surgery and wide local excision in the management of head and neck dermatofibrosarcoma protuberans: a scoping review	8
Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis	8
Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international pat	8
Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years	8
Successful treatment of cutaneous polyarteritis nodosa with baricitinib	8
Whether the transient hair shedding phase exist after minoxidil treatment and does it predict treatment efficacy? A retrospective study in androgenetic alopecia patients	8
A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab	8
Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment	8
A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries	8
Effects and safety of fire needle adjuvant chemical peels therapy in acne vulgaris: a systematic review and meta-analysis	7
Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up st	7
Methylprednisolone and local anesthetic for long-term postherpetic neuralgia: a meta-analysis	7
Baseline hair loss severity as a potential confounder in studies on minoxidil and low-level laser therapy	7
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial	7
Vitiligo exacerbation during upadacitinib treatment for atopic dermatitis and improvement following a switch to abrocitinib: a case report	7
Angiolymphoid hyperplasia with eosinophilia responded well to dupilumab in two cases	7
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?	7
Dupilumab for Hailey-Hailey disease	7
Janus kinase 1 inhibitor abrocitinib for isolated nail lichen planus: a case report and literature review	7
The effects of topical antimicrobial-corticosteroid combination therapy in comparison to topical steroids alone on the skin microbiome of patients with atopic dermatitis	7
Provider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatment	7
Corticosteroid-induced skin damage improved with pimecrolimus cream 1% treatment: a 1-year study in adults with mild to moderate atopic dermatitis	7
Dermatology in a changing world	7
Clinical observations on super relaxation suture in the resection of benign skin tumor in children	7
Expanding the therapeutic horizons of spesolimab: a review of off-label applications for inflammatory skin diseases	7
Amorolfine hydrochloride cream and 2% crisaborole ointment: a study on their therapeutic benefits for keratotic tinea pedis	7
A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study	7
Assessing secondary adherence to topical treatments: scoping review revealing lack of standardized approach in clinical research	7
Letter to the editor submitted in response to “Minoxidil: a comprehensive review”	7
Silicone-induced granulomas successfully treated with adalimumab	7
RETRACTED ARTICLE: Secukinumab-induced paradoxical skin lesions, but successful treatment with tofacitinib in SAPHO syndrome: a case report	7
The impact of hormones in autoimmune cutaneous diseases	6
Comparison of the onset, depth, and duration of cutaneous anesthesia between topical 10% lidocaine and EMLA creams: a randomized, intraindividual, comparative trial	6
Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness	6
UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities	6

Emerging DNA & RNA editing strategies for the treatment of epidermolysis bullosa	6
Efficacy and safety of a novel 785 nm picosecond neodymium-doped yttrium aluminum garnet laser for the treatment of facial benign pigmented lesions in Asian skin: a pilot study	6
Successful guselkumab treatment for a psoriasis patient experiencing an adrenal crisis: a case report	6
Evaluation of β2-microglobulin in the condition and prognosis of psoriasis patients	6
The relative weak way and the absolute strong way to communicate risk information	6
Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne	6
Observational study on postoperative JAK inhibitor and corticosteroid therapy following non-cultured epidermal cell suspension transplantation in stable vitiligo patients	6
Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting	6
Effectiveness and patient satisfaction of a Dutch patient decision aid for psoriasis – a pilot study	6
Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic review and network meta-analyses of randomized trials	6
Two cases of lupus miliaris disseminatus faciei successfully treated with oral tofacitinib	6
CHILD syndrome combined linear porokeratosis in a patient with a good response to the topical lovastatin/cholesterol ointment	6
Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study	6
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals	6
Development of a new classification and scoring system for scalp conditions: Scalp Photographic Index (SPI)	6
Efficacy and safety of oral methotrexate versus oral mini pulse betamethasone therapy in the treatment of lichen planus: a comparative study	6
A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective	6
Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis	6
Patient preferences for atopic dermatitis treatments: a discrete choice experiment	6
Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient	6
Anatomical-based diagnosis and filler injection techniques: marionette line (static labiomandibular fold)	6
Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life	6
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors	6
Preliminary analysis of the efficacy of Mohs micrographic surgery combined with photodynamic therapy in a case of noninvasive extramammary Paget’s disease	6
Exacerbation of psoriasis induced by lenalidomide in a patient with multiple myeloma	6
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials	6
Killing all the birds with one drug – is oral roflumilast a novel treatment option for psoriasis?	6
Health disparities in psoriasis: geographic barriers to access in the United States	6